Dynavax Technologies Corp (NAS:DVAX)
$ 11.11 -0.17 (-1.51%) Market Cap: 1.45 Bil Enterprise Value: 982.21 Mil PE Ratio: 185.17 PB Ratio: 2.35 GF Score: 76/100

Q4 2018 Dynavax Technologies Corp Earnings Call Transcript

Feb 26, 2019 / 09:30PM GMT
Release Date Price: $10.56 (+1.93%)
Operator

Good day, ladies and gentlemen, and welcome to Dynavax Technologies Fourth Quarter and Full Year 2018 Conference Call. (Operator Instructions) As a reminder, this conference is being recorded. I would now like to introduce your host for today's conference, Ms. Heather Rowe, Vice President of Investor Relations and Corporate Communications. You may begin.

Heather Rowe
Dynavax Technologies Corporation - VP of IR & Corporate Communications

Thank you, operator. Good afternoon. Welcome to the Dynavax Fourth Quarter and Full Year 2018 Financial Results Conference Call. With me today are: Eddie Gray, Chief Executive Officer; Rob Janssen, Chief Medical Officer; Michael Ostrach, Chief Financial Officer; and Ryan Spencer, Vice President, commercial operations.

We issued a press release this afternoon and also posted slides to accompany this presentation. The slides can be found under the Investor Relations section of our website, under Events and Presentations. Before we begin, I advise that we will be making forward-looking statements, including statements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot